Cargando…
Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis?
BACKGROUND: Patient-reported outcomes (PROs) aid in rheumatoid arthritis (RA) management, but it is not well understood which measures would be most relevant to the rheumatologists for making treatment decisions. METHODS: We recruited rheumatologists nationally to participate in moderated structured...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727422/ https://www.ncbi.nlm.nih.gov/pubmed/31517249 http://dx.doi.org/10.1186/s41927-019-0087-2 |
_version_ | 1783449247990939648 |
---|---|
author | Jagpal, Aprajita O’Beirne, Ronan Morris, Melanie S. Johnson, Bernadette Willig, James Yun, Huifeng Cherrington, Andrea L. Fraenkel, Liana Curtis, Jeffrey R. Safford, Monika M. Navarro-Millán, Iris |
author_facet | Jagpal, Aprajita O’Beirne, Ronan Morris, Melanie S. Johnson, Bernadette Willig, James Yun, Huifeng Cherrington, Andrea L. Fraenkel, Liana Curtis, Jeffrey R. Safford, Monika M. Navarro-Millán, Iris |
author_sort | Jagpal, Aprajita |
collection | PubMed |
description | BACKGROUND: Patient-reported outcomes (PROs) aid in rheumatoid arthritis (RA) management, but it is not well understood which measures would be most relevant to the rheumatologists for making treatment decisions. METHODS: We recruited rheumatologists nationally to participate in moderated structured group teleconference discussions using the nominal group technique. Participants in each group generated lists of the elements from patient’s history and signs that they use to make treatment recommendations for RA. Each participant then selected the three most important elements from the generated list. The results of each group were then combined and summarized. RESULTS: Twenty-five rheumatologists participated in 4 groups (group size ranged from 4 to 8) and 150 available ranking votes across all groups. The statements generated across the 4 groups were categorized into 13 topics (including symptoms, physical function, comorbidities, social aspects, physical findings, response to treatment, treatment adherence, pain management, side effects, tests, access to care, contraception, and organ involvement), 10 of which received ranking votes. Symptoms received the highest ranking (46% of votes), followed by physical function (16%), and physical findings (13%). Among the unranked topics, social aspects had the highest number of statements (8 statements). CONCLUSION: Rheumatologists highly valued patient-reported RA symptoms and physical function to inform their treatment decisions, even above objective data such as physical findings and test results. These results can guide the selection of validated PRO measures to assess these domains to inform the clinical care of patients with rheumatoid arthritis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s41927-019-0087-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6727422 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-67274222019-09-12 Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis? Jagpal, Aprajita O’Beirne, Ronan Morris, Melanie S. Johnson, Bernadette Willig, James Yun, Huifeng Cherrington, Andrea L. Fraenkel, Liana Curtis, Jeffrey R. Safford, Monika M. Navarro-Millán, Iris BMC Rheumatol Research Article BACKGROUND: Patient-reported outcomes (PROs) aid in rheumatoid arthritis (RA) management, but it is not well understood which measures would be most relevant to the rheumatologists for making treatment decisions. METHODS: We recruited rheumatologists nationally to participate in moderated structured group teleconference discussions using the nominal group technique. Participants in each group generated lists of the elements from patient’s history and signs that they use to make treatment recommendations for RA. Each participant then selected the three most important elements from the generated list. The results of each group were then combined and summarized. RESULTS: Twenty-five rheumatologists participated in 4 groups (group size ranged from 4 to 8) and 150 available ranking votes across all groups. The statements generated across the 4 groups were categorized into 13 topics (including symptoms, physical function, comorbidities, social aspects, physical findings, response to treatment, treatment adherence, pain management, side effects, tests, access to care, contraception, and organ involvement), 10 of which received ranking votes. Symptoms received the highest ranking (46% of votes), followed by physical function (16%), and physical findings (13%). Among the unranked topics, social aspects had the highest number of statements (8 statements). CONCLUSION: Rheumatologists highly valued patient-reported RA symptoms and physical function to inform their treatment decisions, even above objective data such as physical findings and test results. These results can guide the selection of validated PRO measures to assess these domains to inform the clinical care of patients with rheumatoid arthritis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s41927-019-0087-2) contains supplementary material, which is available to authorized users. BioMed Central 2019-09-05 /pmc/articles/PMC6727422/ /pubmed/31517249 http://dx.doi.org/10.1186/s41927-019-0087-2 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Jagpal, Aprajita O’Beirne, Ronan Morris, Melanie S. Johnson, Bernadette Willig, James Yun, Huifeng Cherrington, Andrea L. Fraenkel, Liana Curtis, Jeffrey R. Safford, Monika M. Navarro-Millán, Iris Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis? |
title | Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis? |
title_full | Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis? |
title_fullStr | Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis? |
title_full_unstemmed | Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis? |
title_short | Which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis? |
title_sort | which patient reported outcome domains are important to the rheumatologists while assessing patients with rheumatoid arthritis? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727422/ https://www.ncbi.nlm.nih.gov/pubmed/31517249 http://dx.doi.org/10.1186/s41927-019-0087-2 |
work_keys_str_mv | AT jagpalaprajita whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis AT obeirneronan whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis AT morrismelanies whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis AT johnsonbernadette whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis AT willigjames whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis AT yunhuifeng whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis AT cherringtonandreal whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis AT fraenkelliana whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis AT curtisjeffreyr whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis AT saffordmonikam whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis AT navarromillaniris whichpatientreportedoutcomedomainsareimportanttotherheumatologistswhileassessingpatientswithrheumatoidarthritis |